|
Re: Interesting Uptick
|
2
|
Resverlogix Corp.
|
Apr 28, 2016 01:23PM
|
|
Re: Why didn't RVX run a phase 3 trial on CKD instead of the CVD trial we ran,...
|
2
|
Resverlogix Corp.
|
Apr 26, 2019 12:52PM
|
|
Re: Led Gac
|
2
|
Resverlogix Corp.
|
Jun 08, 2020 05:28PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 22, 2019 12:04PM
|
|
Re: wonder if...
|
2
|
Resverlogix Corp.
|
Oct 24, 2016 02:17PM
|
|
Re: Question re ALP
|
2
|
Resverlogix Corp.
|
Dec 13, 2019 10:10PM
|
|
Re: Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders
|
2
|
Resverlogix Corp.
|
Sep 14, 2018 09:45AM
|
|
Re: Looking for clues:
|
2
|
Resverlogix Corp.
|
Nov 30, 2019 04:42PM
|
|
Re: Key Dates Over the Next Four Months
|
2
|
Resverlogix Corp.
|
Jul 21, 2019 09:30AM
|
|
Re: AHA late breaking abstract
|
2
|
Resverlogix Corp.
|
Nov 10, 2019 01:54PM
|
|
Re: News from a Chinese/Japenese Article about Zenith
|
2
|
Zenith Epigenetics
|
Oct 26, 2016 12:01PM
|
|
BIO-Europe Presentation
|
2
|
Resverlogix Corp.
|
Mar 14, 2018 06:58AM
|
|
FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
2
|
Resverlogix Corp.
|
Mar 12, 2020 09:22AM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
2
|
Resverlogix Corp.
|
Jun 05, 2017 08:58AM
|
|
Re: Was anyone a little nervous? Question for BDZ.....
|
2
|
Resverlogix Corp.
|
Jul 25, 2017 05:29PM
|
|
Denali Interim Phase I/II Data for Hunter Syndrome (MPSII) Clinical Program
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 26, 2021 08:03AM
|
|
BET inhibitor review mentioning RVX-208 and ZEN-3694
|
2
|
Zenith Epigenetics
|
Feb 03, 2019 05:45PM
|
|
Will there be an anniversary gift?
|
2
|
Zenith Epigenetics
|
Jun 14, 2017 10:46PM
|
|
Re: it's up (Biopharm slides)
|
2
|
Resverlogix Corp.
|
Sep 26, 2017 11:34AM
|
|
From CANTOS to CIRT to COLCOT to Clinic
|
2
|
Resverlogix Corp.
|
Mar 12, 2020 09:25AM
|
